Skip to main content

Treatment of Bullous Dermatoses with Ciclosporin (CyA)

  • Conference paper
Ciclosporin in Autoimmune Diseases

Abstract

Today pemphigus vulgaris, including its clinical variants pemphigus foliaceus, pemphigus erythematosus Senear-Usher etc., is generally accepted to be an autoimmune disease with intraepithelial IgG antibodies. For that reason treatment aims at achieving the most effective immunosuppression possible by the systemic administration of steroids and azathioprine and occasionally also methotrexate [7]. If the course of the disease is particularly severe and serum antibody levels are high, plasmapheresis is tried as an additional means of treatment [7, 8]. However, this form of therapy involves considerable side effects because the immunosuppression is not selective. Almost all proliferative cell systems are more or less equally affected by the cytotoxic effects of the above-mentioned drugs, and in particular the immunocompetent cells and the haemopoietic system. A number of authors also report an increased incidence of malignant tumours in patients who receive such immunosuppressive treatment over a prolonged period [6]. In addition there are always patients whose bullous condition cannot be arrested or healed despite the prolonged use of immunosuppressives in high doses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beveridge T (1982) Treatment of auto-immune conditions with Cyclosporin A. In: White DG (ed) Cyclosporin A. Elsevier Biomed Press, Amsterdam New York Oxford, pp 561–564

    Google Scholar 

  2. Beveridge T (1983) Cyclosporin A: An Evaluation of Clinical Results. Transplant Proc XV: 433–437

    Google Scholar 

  3. Beveridge T, Krupp P, McKibbin C (1984) Lymphomas and lymphoproliferative lesions developing under Cyclosporin therapy. Lancet 8380/I:788

    Google Scholar 

  4. Borel JF, Lafferty KJ (1983) Cyclosporine: Speculation about its mechanism of action. Transplant Proc 15:1881–1885

    CAS  Google Scholar 

  5. Borel JF, Stähelin H (1983) Cyclosporin A — Geschichte und Bedeutung seiner Entdeckung. Sandorama 2: 4–8

    Google Scholar 

  6. Kinlen LJ, Sheil AGR, Peto I, et al. (1979) Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J ii:1461–1466

    Article  Google Scholar 

  7. Lever WF, Schaumburg-Lever G (1984) Treatment of pemphigus vulgaris. Arch Dermatol 120:44–47

    Article  PubMed  CAS  Google Scholar 

  8. Ruocco V, Astarita C, Pisani M (1984) Plasmapheresis as an alternative or adjunctive therapy in problem cases of pemphigus. Dermatologica 168:219–223

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Sandoz Ltd, Basle

About this paper

Cite this paper

Balda, BR., Rosenzweig, D. (1985). Treatment of Bullous Dermatoses with Ciclosporin (CyA). In: Schindler, R. (eds) Ciclosporin in Autoimmune Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70607-3_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70607-3_40

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70609-7

  • Online ISBN: 978-3-642-70607-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics